文献速递浆细胞疾病

多发性骨髓瘤患者的亲属中意义未明单克隆丙种球蛋白血症风险与临床及肿瘤特征的关系

Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
PubMed 文献 · Leukemia · 2018-09-10

研究纳入2005至2015年梅奥诊所罗切斯特院区430例多发性骨髓瘤(MM)及冒烟型MM患者,其40岁以上一级亲属1179人提供血清样本筛查意义未明单克隆丙种球蛋白血症(MGUS)。一级亲属中检出MGUS 75例,年龄和性别调整患病率为5.8%(95%CI:4.5-7.2),为预期率的2.4倍(95%CI:1.9-2.9)。家族风险不随先证者诊断年龄、性别、同种型、IgH易位或三体而不同。

要点

  • MM患者一级亲属MGUS年龄和性别调整患病率为5.8%(95%CI:4.5-7.2)。
  • 一级亲属MGUS患病率为预期率的2.4倍(95%CI:1.9-2.9)。
  • 家族风险不随先证者诊断年龄、性别、同种型、IgH易位或三体而不同。

核心结论

  • 研究证实MM病例的一级亲属MGUS风险显著高于一般人群,且不随年龄、性别或肿瘤特征而不同。
  • 在特定情形下,如多个一级亲属受累,可考虑对MM病例的一级亲属进行筛查以用于随访和预防策略。

研究设计与样本

  • 研究纳入2005至2015年梅奥诊所罗切斯特院区招募的MM及冒烟型MM病例430例。
  • 40岁以上一级亲属1179人提供血清样本用于MGUS评估。
  • 一级亲属MGUS的年龄和性别特异性率与基于人群的样本进行比较。
  • 细胞遗传学亚型通过荧光原位杂交分类。

主要发现

  • 一级亲属中检出MGUS 75例,年龄和性别调整患病率为5.8%(95%CI:4.5-7.2)。
  • 一级亲属MGUS患病率为预期率的2.4倍(95%CI:1.9-2.9)。
  • 家族风险不随先证者诊断年龄、性别、同种型、IgH易位或三体而不同。

临床怎么用

  • 作者认为,在特定情形下,如多个一级亲属受累,可考虑对MM病例的一级亲属进行筛查以用于随访和预防策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We and others have shown increased risk of monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of patients with multiple myeloma (MM). Whether familial risk of MGUS differs by the MM proband's age at onset, tumor or clinical characteristics is unknown. MM and smoldering MM (SMM) cases (N = 430) were recruited from the Mayo Clinic in Rochester, Minnesota between 2005-2015. First-degree relatives over age 40 provided serum samples for evaluation of MGUS (N = 1179). Age and sex specific rates of MGUS among first-degree relatives were compared to a population-based sample. Cytogenetic subtypes were classified by Fluorescence in situ hybridization. MGUS was detected in 75 first-degree relatives for an age- and sex- adjusted prevalence of 5.8% (95% CI: 4.5-7.2). Prevalence of MGUS in first-degree relatives was 2.4 fold (95% CI: 1.9-2.9) greater than expected rates. Familial risk did not differ by proband's age at diagnosis, gender, isotype, IgH translocation, or trisomy. This study confirms first-degree relatives of MM cases have a significantly higher risk of MGUS compared to the general population, regardless of age, gender, or tumor characteristics. In selected situations, such as multiple affected first-degree relatives, screening of first-degree relatives of MM cases could be considered for follow-up and prevention strategies.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Clay-Gilmour AI, Kumar S, Rajkumar SV, et al. Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics. Leukemia. 2018. PMID: 30201985. doi:10.1038/s41375-018-0246-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。